Author
Mark S. Schmidt
- Indexed works
- 12
- Total citations
- 2,339
- Active years
- 7
Collaborators
Works in the record
Nature Communications 2016
Open access · CC-BY
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Cell Reports 2019
Open access · CC-BY
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Nature Metabolism 2020
Preprint · OA
Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages
Cell Metabolism 2018
Open access · OA
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
Molecular Cell 2020
Open access · OA
NAD+ Controls Circadian Reprogramming through PER2 Nuclear Translocation to Counter Aging
Science Advances 2023
Open access · CC-BY
Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study
GeroScience 2023
Preprint · OA
A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment
The EMBO Journal 2024
Open access · CC-BY
Control of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function
Hepatology Communications 2020
Open access · CC-BY
Nicotinamide Adenine Dinucleotide Metabolome Is Functionally Depressed in Patients Undergoing Liver Transplantation for Alcohol‐Related Liver Disease
bioRxiv (Cold Spring Harbor Laboratory) 2019
Preprint · CC-BY
Nicotinamide riboside augments the human skeletal muscle NAD + metabolome and induces transcriptomic and anti-inflammatory signatures in aged subjects: a placebo-controlled, randomized trial
Heliyon 2024
Open access · CC-BY
Nicotinamide riboside first alleviates symptoms but later downregulates dopamine metabolism in proteasome inhibition mouse model of Parkinson's disease
bioRxiv (Cold Spring Harbor Laboratory) 2021
Preprint · CC-BY